Scientist, Pharmacology and Toxicology

Position Summary The  Scientist,  Pharmacology and  Toxicology , reporting to the Sr. Director of Pharmacology &  Toxicology  is  an individual contributor who works in a team environment (toxicology, pharmacology, medical/clinical, regulatory, CMC) in  b iotech drug discovery and development .   The position includes study design and  monitoring , development of relationships with  t oxicology CROs and  u niversity  d iscovery  p harmacology activities, data  review , data interpretation, and data presentations .     This include s  exploratory studies and GLP studies to support regulatory filings.  In addition, the  role  will liaise with discovery and development colleagues and  participate  in development of  the overall  toxicology and pharmacology strategies .   The  role  will contribute strategically to the development of  assets   including  present ing  these strategies to the  a sset  d evelopment  t eam as needed to ensure alignment . This role will also  work with external partners such as CROs to conduct the necessary studies to support drug development and to  monitor  study progress.   Key Responsibilities Support the conduct of preclinical toxicology programs for small and large molecules in discovery and development stages.   Propose and support the development of preclinical toxicology strategies to advance programs.   Interface with internal stakeholders in discovery and development.    Interface with MBX regulatory affairs on documents for FDA and other regulatory bodies.   Work with the clinical group to develop nonclinical timelines, and risk-benefit approaches for molecules selected to move forward to FIH trials.   Establish collaborations with CROs and/or academic institutions supporting MBX drug development programs.    Provide tactical support for multiple project teams as they advance molecules from target discovery through lead optimization to clinical development.    Support writing of toxicology and pharmacology sections of regulatory documents, including but not limited to the IND,  IB  and BLA.   Other duties as assigned.    Education   & Qualifications B.S., M.S., or PhD in Toxicology, Pharmacology, or related sciences.     Minimum of 5 years of related experience in biopharma or a CRO.   Excellent communication and interpersonal skills, with the ability to effectively   influence opinion and actions .   C ommunicate strategies, plans, results, and analys e s.    Study directing or  monitoring  experience in the CRO environment .   Demonstrated scientific excellence in the application of toxicology and pharmacology principles across pharmaceutical research and development .   Knowledge of U.S. and International safety guidelines and requirements for pharmaceutical development .   Ability to think strategically and to provide clear direction and expectations to other team members in a highly dynamic environment .   Strong ability to prioritize daily work based on changing business requirements.   Self-motivated, independent, and results oriented.    Ability to work productively in a matrix environment, as a team contributor supporting multiple projects.    Travel This role is expected to be on site 3 days per week. You will be expected to travel periodically based on the needs of the business to the extent requested by the Company, including attendance at Together Weeks, Together Days, and functional meetings as requested by the Company. Company Overview : MBX Biosciences is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP™ platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism preparing for Phase 3 development; and an obesity portfolio that includes MBX 4291 in Phase 1 development and MBX 5765 in preclinical development, as well as additional discovery candidates. The Company is based in Carmel, Indiana and Burlington, Massachusetts. To learn more, please visit the Company website at  www.mbxbio.com  and follow it on LinkedIn. EEO Statement:  MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.